CombiGenes nye vd berttar om sina visioner fr bolaget - BioStock - Connecting Innovation and Capital
| TNBI Stock | USD 0.02 0.01 33.33% |
Under 60% of Tanke Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Tanke Biosciences pink sheet suggests that many investors are alarmed at this time. Tanke Biosciences' investing sentiment shows overall attitude of investors towards Tanke Biosciences.
Tanke |
CombiGenes nye vd berttar om sina visioner fr bolaget BioStock - Connecting Innovation and Capital
Read at news.google.com
 |
Tanke Biosciences Fundamental Analysis
We analyze Tanke Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanke Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanke Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Tanke Biosciences is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Tanke Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tanke Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Tanke Biosciences could also be used in its relative valuation, which is a method of valuing Tanke Biosciences by comparing valuation metrics with similar companies.
Peers
Tanke Biosciences Related Equities
| AWCA | Awaysis Capital | 30.00 | ||||
| ECGR | Bellatora | 6.67 |
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |